Science
Mechanism of Action
Plantaricin A exerts its primary action by forming pores in bacterial cell membranes through interaction with negatively charged phospholipids, leading to membrane depolarization and cell lysis. Specifically, it increases the membrane potential and intracellular Reactive Oxygen Species (ROS) in *Staphylococcus aureus* and inhibits bacterial efflux pumps. It also binds to lipopolysaccharides (LPS) of Gram-negative bacteria like *Escherichia coli*, disrupting outer membrane integrity. In skin, Plantaricin A significantly relieves inflammation by decreasing pro-inflammatory markers such as TNF-α, IL-6, and CRP. It stimulates the proliferation and migration of human keratinocytes, upregulating key genes vital for cell regeneration, including transforming growth factor-β1 (TGF-β1), keratinocyte growth factor 7 (FGF7), vascular endothelial growth factor (VEGF-A), and interleukin-8 (IL-8). Additionally, it supports skin barrier health by reducing phospholipase production by *Malassezia furfur*.
Research
Clinical Evidence
Medium confidenceN/A
Key findings
- 01 Enhanced the activity of Ciprofloxacin and Trimethoprim against *Staphylococcus aureus*, effectively inhibiting bacterial growth.
- 02 Inhibited methicillin-resistant *S. aureus* (MRSA) on wound surfaces in mice when combined with Ciprofloxacin, significantly relieving inflammation (decreasing TNF-α, IL-6, and CRP) and promoting wound healing.
- 03 Significantly enhanced the proliferation and migration of human keratinocytes (NCTC 2544 cells) and upregulated the expression of key regenerative genes (TGF-β1, FGF7, VEGF-A, and IL-8), demonstrating a superior inductive effect compared to hyaluronic acid.
Transparency
Dusting Analysis
The Formula
Formulation
Stability
Plantaricin A exhibits good stability across a broad pH range of 2.0 to 8.0, with activity diminishing significantly at pH levels above 8.0-9.0. It also demonstrates thermal stability, maintaining activity after exposure to 100°C for 30 minutes, and partial activity at 120°C. However, its activity is completely lost when treated with proteolytic enzymes such as pepsin, papain, proteinase K, trypsin, and chymotrypsin.
Conflicts
- Proteolytic enzymes (pepsin, papain, proteinase K, trypsin, chymotrypsin)
- Strong alkaline conditions (pH > 8.0-9.0)
- Magnesium ions, calcium, lecithin, and lipopolysaccharides (LPS) may reduce its membrane-penetrating ability, which requires careful formulation consideration.
Safety
Safety Profile
*Lactobacillus plantarum*, the bacterium from which Plantaricin A is derived, is recognized as a Generally Recognized As Safe (GRAS) microorganism. While this suggests a favorable safety profile, Plantaricin A itself has not undergone specific safety assessments by cosmetic regulatory bodies like CIR or SCCS. It is noteworthy that *in vitro* studies at concentrations of 1-50 μM have shown Plantaricin A to induce cell death in cancerous lymphoid cells (Reh, Jurkat) and normal B and T cells, and cause membrane permeabilization or lysis in PC12 cells. The relevance of these *in vitro* cytotoxic effects at higher concentrations to typical topical cosmetic application warrants further investigation and precise formulation control.
Your Skin
Skin Compatibility
Our Assessment
Verdict
Plantaricin A is a valuable peptide for targeted skin concerns, offering potent antimicrobial, anti-inflammatory, and regenerative benefits, though careful formulation is crucial given its *in vitro* cytotoxicity at higher concentrations and current lack of specific cosmetic safety reviews.
Related
Similar Ingredients
Finding similar ingredients…